Vol. 50 No. sup 1 (2011): Acta Oncologica

Articles

• Introduction from the chairmen of the WHO International Consultation on Prostate cancer

  Sten Nilsson, Lennart Andersson

  1

  Published: 2011-06-01

  • PDF

• Introduction

  Steven Joniau

  24

  Published: 2011-06-01

  • PDF

• Role of histopathology and molecular markers in the active surveillance of prostate cancer

  Rodolfo Montironi, Lars Egevad, Anders Bjartell, Daniel M. Berney

  56-60

  Published: 2011-06-01

  • PDF

• Radical retropubic prostatectomy: A review of outcomes and side-effects

  Jonas Hugosson, Johan Stranne, Sigrid V. Carlsson

  92-97

  Published: 2011-06-01

  • PDF

• When is active surveillance the appropriate treatment for prostate cancer?

  Peter C. Albertsen

  120-126

  Published: 2011-06-01

  • PDF

• WHO International Consultation on Prostate Cancer: A summary

  Peter C. Albertsen

  155-160

  Published: 2011-06-01

  • PDF

• The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: The prostate cancer screening results in context

  Christine D. Berg

  12-17

  Published: 2011-06-01

  • PDF

• Pathology in prostate research: Optimizing the pathological data

  Daniel M Berney, Rodolfo Montironi, Lars Egevad

  49-52

  Published: 2011-06-01

  • PDF

• Tumour markers in prostate cancer III: Biomarkers in urine

  Monique J. Roobol, Alexander Haese, Anders Bjartell

  85-89

  Published: 2011-06-01

  • PDF

• Hypofractionation for radiotherapy of prostate cancer using a low alfa/beta ratio – possible reasons for concerns? An example of five dimensional radiotherapy

  Bo Lennernäs, Sten Nilsson, Seymour Levitt

  111-115

  Published: 2011-06-01

  • PDF

• Broadening horizons in medical management of prostate cancer

  Saroj Niraula, Ian F. Tannock

  141-147

  Published: 2011-06-01

  • PDF

• Screening for prostate cancer: Defining critical issues

  Lars Holmberg, Olof Akre

  2-3

  Published: 2011-06-01

  • PDF

• State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer

  Stijn W. T. P. J. Heijmink, Jurgen J. Fütterer, Stephen S. Strum, Wim J. G. Oyen, Ferdinand Frauscher, J. Alfred Witjes, Jelle O. Barentsz

  25-38

  Published: 2011-06-01

  • PDF

• Tumor markers in prostate cancer I: Blood-based markers

  Shahrokh F. Shariat, Axel Semjonow, Hans Lilja, Caroline Savage, Andrew J. Vickers, Anders Bjartell

  61-75

  Published: 2011-06-01

  • PDF

• Curative radiation therapy in prostate cancer

  Ulrika Harmenberg, Freddie C. Hamdy, Anders Widmark, Bo Lennernäs, Sten Nilsson

  98-103

  Published: 2011-06-01

  • PDF

• Chemoprevention of prostate cancer

  Roger S. Rittmaster

  127-136

  Published: 2011-06-01

  • PDF

• Early detection of prostate cancer with emphasis on genetic markers

  Markus Aly, Fredrik Wiklund, Henrik Grönberg

  18-23

  Published: 2011-06-01

  • PDF

• Pathology in prostate research: Optimizing tissue quality

  Daniel M. Berney, Rodolfo Montironi, Lars Egevad

  53-55

  Published: 2011-06-01

  • PDF

• Introduction: Therapy with curative intent

  Sten Nilsson, Gabriella Cohn-Cedermark, Peter Wiklund

  90-91

  Published: 2011-06-01

  • PDF

• Natural history of prostate cancer, chemoprevention and active surveillance

  Ola Bratt, Martin C. Schumacher

  116-119

  Published: 2011-06-01

  • PDF

• Prostate cancer from the horizon of the patient

  Louis J. Denis, Monique Roobol, Brigitte Dourcy-Belle-Rose

  148-154

  Published: 2011-06-01

  • PDF

• Screening for prostate cancer – The controversy continues, but can it be resolved?

  Meelan Bul, Fritz H. Schröder

  4-11

  Published: 2011-06-01

  • PDF

• Developing imaging strategies for castration resistant prostate cancer

  Josef J. Fox, Michael J. Morris, Steven M. Larson, Heiko Schöder, Howard I. Scher

  39-48

  Published: 2011-06-01

  • PDF

• Tumour markers in prostate cancer II: Diagnostic and prognostic cellular biomarkers

  Anders Bjartell, Rodolfo Montironi, Daniel M. Berney, Lars Egevad

  76-84

  Published: 2011-06-01

  • PDF

• Four and five dimensional radiotherapy with reference to prostate cancer – definitions, state of the art and further directions – an overview

  Bo Lennernäs, Enrique CastellanoS, Sten Nilsson, Seymour Levitt

  104-110

  Published: 2011-06-01

  • PDF

• Management of advanced prostate cancer – new drugs

  Anders Ullén, Carl-Henrik Shah, Ziya Kirkali

  137-140

  Published: 2011-06-01

  • PDF